GlassScriptPhysician profile
Adam M Buerk
NPI 1902038037
$30,657.34
in general payments reported to CMS, 2019-2025
9 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $126 · 2021: $6,059 · 2022: $1,806 · 2023: $5,963 · 2024: $1,200 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,700 · Education: $1,200 · Food and Beverage: $470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,700.00 |
| Education | $1,200.00 |
| Food and Beverage | $470.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maxx Orthopedics, INC. | $15,076.92 | 2019 | |
| Zimmer Biomet Holdings, INC. | $15,065.37 | 2019-2024 | Rosa, Persona The Personalized Knee Osseoti, Mymobility Platform |
| Baxter Healthcare | $278.03 | 2022-2025 | Tisseel |
| Orthopediatrics Corp. | $72.39 | 2023 | |
| Stryker Corporation | $62.98 | 2019 | |
| Biocomposites INC | $51.49 | 2025 | Stimulan |
| Pacira Pharmaceuticals Incorporated | $20.77 | 2023 | Zilretta, Iovera, Exparel |
| Pacira Therapeutics, INC. | $16.52 | 2020 | |
| Medtronic USA, INC. | $12.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Buerk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.